EB-101 Surgical application of RDEB wounds

Drug identity checked against registry records

Also recorded as pz-cel

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsNCT05725018ABEOPhase 3Active not recruiting2025-09-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.